WHO approves Sinopharm’s COVID-19 vaccine for use in emergency situations
Vero Cell’s inactivated COVID-19 vaccine, along with three other vaccines, is on the WHO Emergency Use List.
Author name: Olga Onisko
The bright and dark sides of vaccine diplomacy
The COVID-19 pandemic has brought a lot of new terms. One of them was “vaccine diplomacy.”
Who owns the pharmacy?
We continue to publish extracts from the report on the activities of community pharmacies in the WHO European Region, which touch on the most important aspects of their work.
“Rare are many”: February 28 is International Rare Disease Day
International Rare Disease Day is held every year on the last day of February. Its main goal is to raise awareness about rare diseases and people living with them.
Archibald Cochran is the father of evidence-based medicine
A better alternative to experience Traditionally, the practice of medicine has always been based on the personal experience of the physician in each area of health care. However, this experience is ve...
Scientists have created the world’s first digital prescription cure for insomnia
Pear Therapeutics has released the Somryst app, the first digital prescription drug for insomnia.
New diagnostic test could save up to two million lives a year
Engineers at Monash University in Australia have developed a fast, portable and cheap diagnostic test that could potentially save up to two million lives every year.
Scripps Research scientists have developed a new strategy for treating retinal diseases
Scientists have discovered a potential drug to treat eye diseases that affect millions of people around the world.
A diet high in flavonoids lowers blood pressure
Foods and drinks rich in flavanols (tea, cocoa, apples and berries) help lower blood pressure.
Prospects for mRNA COVID-19 vaccines from Moderna, Pfizer and BioNTech may be on ice
The mRNA vaccines being developed by Moderna and Pfizer have strict storage requirements that could hurt their prospects.
Scientists at Washington University School of Medicine in St. Louis are working on a nasal vaccine against COVID-19
Experiments on animal models have shown that it is effective in killing infected mice susceptible to the new coronavirus.